BRIEF-United Therapeutics Announces Advance Outcomes Study Of Ralinepag

United Therapeutics Corporation

United Therapeutics Corporation

UTHR

0.00

May 17 (Reuters) - United Therapeutics Corp UTHR.O:

  • UNITED THERAPEUTICS CORPORATION ANNOUNCES ADVANCE OUTCOMES STUDY OF RALINEPAG PRESENTED AT ATS 2026

  • UNITED THERAPEUTICS CORP: PHASE 3 ADVANCE OUTCOMES STUDY MET ITS PRIMARY ENDPOINT

Source text: ID:nBw11vXBya

Further company coverage: UTHR.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.